Cell Therapeutics (CTIC)
Cell Therapeutics Balance Sheet
- Quarterly: March 2012 - December 2009 Previous Quarters
- Annual
| Assets | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Cash & Short Term Investments | 27.38M | 47.05M | 45.21M | 38.89M | 43.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Receivables | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Inventory | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Prepaid Expenses | 4.544M | 4.023M | 4.692M | 3.907M | 3.798M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Other Current Assets | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Assets | 31.92M | 51.08M | 49.90M | 42.79M | 47.61M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Gross Property, Plant & Equipment | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Accumulated Depreciation | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Net Property, Plant & Equipment | 4.261M | 3.604M | 4.309M | 4.517M | 4.091M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Long Term Investments | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Goodwill & Intangibles | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Assets | 7.965M | 7.56M | 8.637M | 9.272M | 9.22M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Assets | 12.23M | 11.16M | 12.95M | 13.79M | 13.31M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Assets | 44.15M | 62.24M | 62.85M | 56.58M | 60.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Liabilities | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Current Portion of Long Term Debt | 0.563M | 0.97M | 13.82M | 14.02M | 24.16M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accounts Payable | 5.491M | 5.75M | 6.564M | 7.307M | 5.459M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Accrued Expenses | 8.928M | 11.06M | 10.42M | 15.45M | 9.483M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Deferred Revenues | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Current Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Current Liabilities | 14.98M | 17.78M | 30.81M | 36.78M | 39.10M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Long Term Debt | 3.52M | 2.985M | 3.088M | 3.442M | 4.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Shareholder's Equity | 2012-03 | 2011-12 | 2011-09 | 2011-06 | 2011-03 | 2010-12 | 2010-09 | 2010-06 | 2010-03 | 2009-12 |
| Deferred Income Tax | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Minority Interest | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Long Term Liabilities | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Total Long Term Liabilities | 3.52M | 2.985M | 3.088M | 3.442M | 4.01M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities | 18.50M | 20.77M | 33.90M | 40.22M | 43.11M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Common Shares Outstanding | 226.58M | 203.07M | 192.80M | 175.23M | 167.75M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Preferred Stock | 6.736M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | ||||
| Common Stock, Net | 1.753B | 1.745B | 1.721B | 1.680B | 1.658B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Additional Paid-in Capital | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Retained Earnings | -1.732B | -1.715B | -1.697B | -1.667B | -1.645B | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Treasury Stock | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro | |||||
| Other Shareholder's Equity | -0.791M | -0.708M | -0.628M | -0.563M | -0.52M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Shareholder's Equity | 25.65M | 41.47M | 28.95M | 16.36M | 17.81M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
| Total Liabilities & Shareholder's Equity | 44.15M | 62.24M | 62.85M | 56.58M | 60.92M | Go Pro | Go Pro | Go Pro | Go Pro | Go Pro |
